Broadview Heights, OH, United States of America

Hongqiao Wu

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Abrexa Pharmaceuticals, Inc., Research Development Foundation, Polymer Additives Inc.. Active years: 2017-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hongqiao Wu. Retrieved from https://idiyas.com/inventor/hongqiao-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 1

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 3(Granted Patents)

Location History:

Concord, OH (US) (2019 - 2021)
Broadview Heights, OH (US) (2017 - 2023)

Company Filing History:

2 out of 5

Abrexa Pharmaceuticals, Inc.

patents

2 out of 299

Research Development Foundation

patents

1 out of 2

Polymer Additives Inc.

patents

Years Active: 2017-2023

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11584711 - 2,2,2-trifluoroacetic acid 1-(2,4-dimethylphenyl)-2-[(3-methoxyphenyl)methylene] method of making the same (2023-02-21),

2. 10968167 - 2,2,2-trifluoroacetic acid 1-(2,4-Dimethylphenyl)-2-[(3-methoxyphenyl)methylene] hydrazide polymorphs and method of making the same (2021-04-06),

3. 10934267 - Alpha-tea salt forms: compositions and uses for treating disease (2021-03-02),

4. 10370350 - Alpha-TEA salt forms: compositions and uses for treating disease (2019-08-06),

5. 9676924 - Triesters from alpha-and-beta-hydroxyesters (2017-06-13),

Title: Innovations of Hongqiao Wu

Introduction

Hongqiao Wu is a notable inventor based in Broadview Heights, OH (US). He has made significant contributions to the field of neurotrophic agents, holding a total of 5 patents. His work focuses on the development of crystalline polymorph forms of specific chemical compounds.

Latest Patents

Wu's latest patents include innovative methods for producing crystalline polymorphs of neurotrophic agents. One of his notable patents is for the compound 2,2,2-trifluoroacetic acid 1-(2,4-dimethylphenyl)-2-[(3-methoxyphenyl)methylene] hydrazide (J147). This patent outlines the process for creating crystalline polymorphic forms of this compound, which has potential applications in neurobiology.

Career Highlights

Throughout his career, Hongqiao Wu has worked with various organizations, including the Research Development Foundation and Abrexa Pharmaceuticals, Inc. His experience in these companies has contributed to his expertise in the field of pharmaceuticals and chemical development.

Collaborations

Wu has collaborated with several professionals in his field, including Michael O'Neill and Barbara Kidon. These collaborations have likely enhanced his research and development efforts.

Conclusion

Hongqiao Wu's contributions to the field of neurotrophic agents through his patents and collaborations highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.